Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
apheresis, Adult, antibodies, Biological, HSCs, ALL, AML, Leukemia, Diseases, bioengineering, bone marrow, Non-Biological, Therapies, biopsy, cell regulation, GVHD, Pediatric, Adverse Events, MDS, enzyme inhibitors, Biological Processes, MPN, gene therapy, cell expansion, Technology and Procedures, immune cells, Immune Disorders, Young Adult, cytogenetics, immunotherapy, Cell Lineage, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, Myeloid Malignancies, NK cells, genomics, Quality Improvement , hematopoiesis, immune mechanism, flow cytometry, transplantation, TKI, inflammation, stem cells, molecular testing, vaccines, signal transduction
Type: Oral
Hematology Disease Topics & Pathways:
apheresis, Adult, antibodies, Biological, HSCs, ALL, AML, Leukemia, Diseases, bioengineering, bone marrow, Non-Biological, Therapies, biopsy, cell regulation, GVHD, Pediatric, Adverse Events, MDS, enzyme inhibitors, Biological Processes, MPN, gene therapy, cell expansion, Technology and Procedures, immune cells, Immune Disorders, Young Adult, cytogenetics, immunotherapy, Cell Lineage, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, Myeloid Malignancies, NK cells, genomics, Quality Improvement , hematopoiesis, immune mechanism, flow cytometry, transplantation, TKI, inflammation, stem cells, molecular testing, vaccines, signal transduction
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Moderators:
Ken-Ichi Matsuoka, MD, PhD, Okayama University Hospital
and
Rohtesh S. Mehta, MD, MPH, MS, The University of Texas MD Anderson Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH